Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double‐blind, placebo‐controlled trial

Abstract Bone marrow‐derived cells contribute to tissue repair, but traffic of hematopoietic stem/progenitor cells (HSPCs) is impaired in diabetes. We therefore tested whether HSPC mobilization with the CXCR4 antagonist plerixafor improved healing of ischemic diabetic wounds. This was a pilot, phase...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Benedetta Maria Bonora, Roberta Cappellari, Marta Mazzucato, Mauro Rigato, Marco Grasso, Mirko Menegolo, Andrea Bruttocao, Angelo Avogaro, Gian Paolo Fadini
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Oxford University Press 2020-09-01
סדרה:	Stem Cells Translational Medicine
נושאים:	angiogenesis CD34+ clinical translation diabetes hematopoietic stem cells mobilization
גישה מקוונת:	https://doi.org/10.1002/sctm.20-0020
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!